Skin Testing and Drug Provocation Tests Should Be Performed in the Context of Drug Reaction with Eosinophilia and Systemic Symptoms: A Cohort Study
Dermatitis® · 2024
DOI: 10.1089/derm.2023.0291 ↗Kurz gefasst
Leserbrief in der Zeitschrift Dermatitis®, 2024. Verfasst von Élise Toulemonde und 7 weiteren Autor:innen. Beteiligte Einrichtung: Service de dermatologie CHU Lille Université de Lille Lille France. Hauptthemen laut MEDLINE: Drug Hypersensitivity Syndrome, Skin Tests. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Service de dermatologie CHU Lille Université de Lille Lille France.
- CHU Lille Institut de Pharmacie Lille France.
- GRITA Groupe de Recherche sur les Formes Injectables et les Technologies Associées Université de Lille Lille France.
- Centre régional de pharmacovigilance CHU Lille Université de Lille Lille France.
- U1286 Inserm INFINITE Institute for Translational Research in Inflammation Lille France.
ORCID-Profile: Frédéric Dezoteux
Zitieren
APA
Toulemonde, É., Lannoy, D., Gautier, S., Stéfanski, M., Miaux, C., Azib-Meftah, S., Staumont-Sallé, D., & Dezoteux, F. (2024). Skin Testing and Drug Provocation Tests Should Be Performed in the Context of Drug Reaction with Eosinophilia and Systemic Symptoms: A Cohort Study. Dermatitis®. https://doi.org/10.1089/derm.2023.0291
Vancouver
Toulemonde É, Lannoy D, Gautier S, Stéfanski M, Miaux C, Azib-Meftah S, et al. Skin Testing and Drug Provocation Tests Should Be Performed in the Context of Drug Reaction with Eosinophilia and Systemic Symptoms: A Cohort Study. Dermatitis®. 2024. doi:10.1089/derm.2023.0291
BibTeX
@article{Toulemonde2024,
author = {Toulemonde, Élise and Lannoy, Damien and Gautier, Sophie and Stéfanski, Marion and Miaux, Céline and Azib-Meftah, Selma and Staumont-Sallé, Delphine and Dezoteux, Frédéric},
title = {Skin Testing and Drug Provocation Tests Should Be Performed in the Context of Drug Reaction with Eosinophilia and Systemic Symptoms: A Cohort Study},
journal = {Dermatitis®},
year = {2024},
doi = {10.1089/derm.2023.0291}
}
EUVIMED